Melasma is a complex pigmentation condition triggered by factors such as hormones, UV exposure, and inflammation. It requires precise, medically guided treatment. At South Yarra Dermatology, we focus on identifying your unique triggers and skin behaviour to create a targeted plan that restores clarity and supports long-term management.
Melasma can be discouraging, particularly when it fades and returns without clear warning. Our first step is to understand your pattern: when it started, what appears to trigger it, and how it affects you.
From there, we create a plan that suits your skin and your lifestyle. Melasma takes time to manage, but with the right approach and clear guidance, meaningful improvement is achievable. We guide you through each stage of treatment.
Before we talk about treatments, we begin with your sto
Melasma can be discouraging, particularly when it fades and returns without clear warning. Our first step is to understand your pattern: when it started, what appears to trigger it, and how it affects you.
From there, we create a plan that suits your skin and your lifestyle. Melasma takes time to manage, but with the right approach and clear guidance, meaningful improvement is achievable. We guide you through each stage of treatment.
Every skin story is different, and so is every approach to melasma care. Before recommending treatments, we take time to understand when your acne began, what triggers it, and how it affects your daily life. This helps us create a plan that’s tailored to your skin and your goals.
Best for: All melasma patients; essential foundation for all other treatments
Downtime: None, ongoing commitment to daily routines
While lifestyle changes alone rarely eliminate established melasma, they form an essential foundation. Without addressing the root triggers, particularly sun exposure, even the most effective treatments yield limited results, and improvements are often temporary. UV protection, hormonal awareness, and careful skincare choices work together to stabilise the skin’s pigment response and create the conditions for treatment success.
Best for: Mild to moderate melasma, maintenance treatment, and combination approaches.
Downtime: None; initial adjustment period of 2-6 weeks with possible mild irritation or dryness
Topical treatments form the core of effective melasma management, reducing pigmentation by regulating melanin production and supporting skin renewal. We select proven options based on your skin’s response, sensitivity, and long-term goals. When a single ingredient isn’t enough, we may recommend combination therapy to enhance results. Above all, we prioritise treatments you can use consistently and comfortably to ensure both efficacy and long-term skin health.
Best for: Moderate to severe melasma, refractory cases, and patients seeking comprehensive systemic support
Downtime: None; certain medications require periodic monitoring
We use oral therapies to address internal factors that contribute to melasma, helping to regulate pigment from within. We may consider these options when topical treatments alone have not provided sufficient improvement or when pigmentation is widespread. By working systemically, they can support clearer, more even skin and help maintain long-term results under professional guidance.
Best for: Mild to moderate melasma, epidermal pigmentation, and cases requiring accelerated results
Downtime: Light peeling for 3-7 days; deeper peels may require 7-10 days of mild social downtime
We use chemical peels to gently remove surface pigment and stimulate healthy skin renewal, making them effective for melasma that sits in the upper layers of the skin. Depending on the depth of your pigmentation and skin type, we tailor the strength and frequency of peels to achieve gradual, controlled improvement over time.
Melasma most commonly affects adults, particularly women of reproductive age, though it can occur at various life stages. Whether you’re experiencing hormonal changes, noticing pigmentation after sun exposure, or managing long-standing patches, our dermatologists provide personalised care to address contributing factors and improve skin clarity.
During your initial consultation, we take time to understand your skin’s history, what you’ve tried previously, and how melasma is affecting your life. This comprehensive assessment forms the foundation for a treatment plan designed around your individual needs and circumstances.
We’ll discuss each recommendation in detail: what it involves, realistic timelines, and what you can expect. Our focus is on providing effective, evidence-based treatment delivered with genuine care and attention.
Melasma is a chronic skin condition marked by symmetrical dark patches, usually on the face, caused by overproduction of melanin. It develops through a combination of genetics, sun exposure, hormones, skin type, and inflammation.
Individuals with a family history or darker skin are more susceptible due to naturally higher melanin activity. Factors such as UV exposure, hormonal fluctuations during pregnancy or contraceptive use, certain medications, irritating skincare products, and stress can trigger or worsen the condition. Melasma occurs when several of these factors align, which is why effective treatment requires identifying and managing the underlying causes, not just the visible pigmentation.
Melasma is a chronic condition, meaning the underlying trigger for excess pigment production remains active, so pigmentation can return if treatment and sun protection stop. While it is not curable in the traditional sense, it is highly manageable. Many patients maintain the majority of their improvement long term with consistent care.
Like other chronic skin conditions, such as rosacea or psoriasis, melasma responds well to ongoing management. The key to long-term success is shifting from seeking a permanent cure to adopting sustained maintenance as part of regular skincare.
Yes. Sun protection, consistency, and patience are essential to melasma treatment. UV exposure is the primary trigger for pigmentation, so without strict SPF 50+ use, protective clothing, and shade, even the best treatments will not work effectively. Daily adherence to your treatment plan over several months, not sporadic use, is what leads to improvement.
With consistent protection and realistic expectations, meaningful results become achievable. Without them, progress is minimal and temporary.
Melasma treatment timelines vary based on pigmentation depth, skin type, and treatment consistency. Mild cases with superficial pigmentation may show visible improvement in 8 to 12 weeks and achieve moderate reduction within 4 to 6 months. Moderate or mixed-depth melasma often requires 6 to 12 months of steady treatment for significant improvement, while deeper dermal melasma, especially in darker skin, may take 12 months or more to achieve moderate improvement.
Complete clearance is not guaranteed, but meaningful visible results are achievable for most patients with consistent treatment. Ongoing maintenance and strict sun protection are essential, as melasma is chronic and can return without continued care.
Yes, melasma often returns if sun protection or other preventive measures are stopped because the underlying tendency for pigment overproduction remains. Sun exposure or hormonal changes can reactivate melanocytes, leading to recurrence.
However, once melasma has been treated and controlled, future flare-ups are usually milder and caught earlier. The most effective long-term strategy is transitioning to maintenance therapy, such as ongoing sun protection and periodic professional or topical treatments, which helps prevent recurrence while requiring less effort than initial treatment.
While melasma cannot always be prevented, especially if you have a genetic predisposition or darker skin, you can significantly lower your risk and prevent worsening by protecting your skin from UV exposure, managing hormonal influences, avoiding irritating skincare, reducing inflammation, and being aware of medications that increase sun sensitivity.
Daily use of broad-spectrum SPF 50+, protective clothing, and lifestyle measures like stress reduction and gentle skincare can delay melasma onset or keep existing melasma under control, even if you remain prone to it.
Skin tone significantly influences both melasma prevalence and treatment strategy. Individuals with darker skin, particularly those of Hispanic, Asian, Middle Eastern, African, and South Asian descent, develop melasma at substantially higher rates than lighter-skinned individuals. Genetic predisposition and higher baseline melanin production create greater vulnerability to melanocyte dysregulation.
Darker skin tones also face unique treatment challenges. Post-inflammatory hyperpigmentation (PIH), where inflammation from treatment itself creates darker marks, occurs more readily in darker skin. This means that aggressive treatments recommended for lighter skin can worsen pigmentation in darker skin while attempting to address melasma.
A dermatologist can assess how deep melanin sits in the skin using clinical examination and a Wood’s lamp, which helps distinguish between epidermal (surface) and dermal (deeper) pigmentation. This matters because epidermal melasma responds well to topical treatments and peels, while dermal melasma requires more complex, layered therapies and progresses more slowly.
Most patients have mixed melasma, which needs a strategic combination approach. Professional evaluation is essential for choosing the right treatment and avoiding ineffective results.
Chemical peels remove pigmented skin cells and stimulate renewal, making them effective for surface-level melasma and helpful, when combined with other treatments, for deeper pigmentation. In darker skin tones, the main risk is post-inflammatory hyperpigmentation, where irritation triggers additional pigment production.
To prevent this, dermatologists use gentler acids like mandelic acid, lower concentrations, shorter application times, and gradual progression based on skin tolerance. With proper customisation and sun protection, chemical peels can be recommended for melasma in deeper skin tones, but they must be tailored rather than using a universal approach.
Pregnancy significantly increases melasma risk, but treatment options are limited during this time. Most topical therapies are avoided due to safety concerns, with sun protection serving as the primary management strategy. Chemical peels may be recommended but are often deferred until after pregnancy or breastfeeding. Melasma that appears during pregnancy sometimes improves after delivery but may persist.
During breastfeeding, more treatments become available, but any active ingredient should still be discussed with your healthcare provider.
Once you have achieved improvement through intensive treatment, the question becomes how to maintain those results long-term. This typically involves a combination of sun protection, gentler topical therapy, and periodic professional treatments.
Sun protection forms the foundation. This does not change. Daily SPF 50+ broad-spectrum sunscreen, reapplication every two hours outdoors, protective clothing, and shade-seeking during peak hours remain essential indefinitely.
Maintenance topical therapy is usually gentler than acute treatment but applied consistently. This might involve using hydroquinone two to three times weekly rather than daily, or transitioning to azelaic acid or niacinamide-based products for daily maintenance. Many patients find that lower-intensity, consistent application prevents recurrence better than cyclical use.
Periodic professional peels (monthly superficial peels or quarterly medium-depth peels) prevent pigmentation accumulation. Many patients find that brief peels every 4 to 6 weeks maintain improvement without requiring intensive treatment.
Seasonal intensification works well for some patients. During high-sun seasons (summer), increasing sun protection, potentially adding oral tranexamic acid, or scheduling peels more frequently prevents seasonal worsening. During lower-sun seasons, less intensive maintenance often suffices.
Monitoring for hormonal changes matters for patients whose melasma is linked to contraceptive use or hormone therapy. If you change medications or stop therapy, that shift in hormonal status might necessitate adjusted melasma management.
Successful long-term management typically requires less intensive commitment than acute treatment but more than none. Think of it as your ongoing approach to melasma: continued attention that prevents recurrence and maintains improvement. Patients who embrace this perspective achieve the best long-term outcomes.
While primary care physicians can discuss melasma, specialised dermatological expertise typically yields better outcomes. Melasma assessment and treatment planning require pattern recognition developed through extensive experience. Determining whether melasma is primarily epidermal or dermal influences recommendations fundamentally. Selecting appropriate treatments for individual skin types requires nuance. The peeling protocols recommended for lighter skin differ substantially from appropriate approaches for darker skin. Recognising and managing treatment complications like post-inflammatory hyperpigmentation requires specific expertise.
Additionally, dermatologists have access to the complete range of treatments: topical therapies, professional peels, and advanced procedures that primary care providers might not offer.
That said, primary care physicians play an important role. If melasma developed with oral contraceptive use or during hormone therapy, your primary care doctor’s input on whether medication changes might help is valuable. If melasma relates to an underlying medical condition or medication, addressing that is essential.
The ideal approach often involves collaboration: your dermatologist designs and oversees the melasma treatment plan while your primary care doctor addresses any underlying medical contributors.
